GP-Act III Acquisition (GPAT) Shares Outstanding (Diluted Average) (2023 - 2025)

GP-Act III Acquisition has disclosed Shares Outstanding (Diluted Average) across 3 years of filings, most recently posting $28.8 million for Q4 2025.

• Quarterly Shares Outstanding (Diluted Average) rose 319.9% year-over-year to $28.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28.8 million (up 319.9% YoY) and the FY2025 annual result came in at $28.8 million, up 319.9% from the prior year.
• Shares Outstanding (Diluted Average) steadied at $28.8 million in Q4 2025, from $28.8 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $28.8 million in Q1 2025 and troughed at $6.2 million in Q1 2023.
• A 3-year average of $12.2 million and a median of $6.8 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Biggest YoY gain for Shares Outstanding (Diluted Average) was 360.0% in 2025; the steepest drop was 5.73% in 2025.
• Tracing GPAT's Shares Outstanding (Diluted Average) over 3 years: stood at $6.2 million in 2023, then advanced by 9.55% to $6.8 million in 2024, then jumped by 319.9% to $28.8 million in 2025.
• Business Quant data shows GPAT's Shares Outstanding (Diluted Average) at $28.8 million in Q4 2025, $28.8 million in Q3 2025, and $7.2 million in Q2 2025.